Whereas, the cytokine abrogating effects of biologicals and novel JAK/STAT inhibitors might have a role in the treatment of sIgAD or other hypogammaglobinaemia's with concomitant autoimmunity. Here, SOAT1 is linked to selective IgA deficiency disease.